.svg){kind=small}
Mar-2026
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Kikoko's performance in the California market presents a mixed picture across different product categories. In the Beverage category, the brand maintained a steady position at rank 14 from January to March 2026, despite a notable decline in sales from December 2025 to February 2026. This consistency in ranking suggests a stable market presence despite fluctuating sales figures. On the other hand, Kikoko's Capsules category experienced a slight dip in rankings, moving from 4th place in December 2025 to 6th place by February 2026, before stabilizing. This movement indicates increased competition or shifts in consumer preferences within the category.
The Edible category tells a different story for Kikoko in California. The brand was unable to break into the top 30 rankings for this category, as evidenced by its position slipping from 40th in December 2025 to 42nd by March 2026. This consistent absence from the top 30 suggests that Kikoko faces significant challenges in gaining traction in the Edible market, possibly due to strong competition or a less favorable consumer perception. The contrasting performances across these categories highlight the varying dynamics and market pressures that Kikoko navigates within the California cannabis landscape.
Competitive Landscape
In the competitive landscape of the California cannabis capsules market, Kikoko has experienced a notable shift in its ranking and sales performance from December 2025 to March 2026. Initially holding a strong position at rank 4, Kikoko maintained this rank through January 2026 but saw a decline to rank 6 by February and March 2026. This drop coincides with a significant decrease in sales, particularly from January to February 2026. In contrast, Buddies improved its rank from 5 to 4 during the same period, overtaking Kikoko, and demonstrated a strong sales recovery by March 2026. Meanwhile, Emerald Bay Extracts also showed a positive trend, climbing from rank 6 to 5 and increasing its sales, which may have contributed to the competitive pressure on Kikoko. Brands like Dr. Norm's and The Tablet remained stable in their lower ranks, indicating a less direct impact on Kikoko's position. These dynamics suggest that Kikoko faces increasing competition and may need strategic adjustments to regain its higher market standing.
Notable Products
In March 2026, Kikoko's top-performing product was the XTabs - Sativa High Dose Tablets 20-Pack (1000mg), maintaining its first-place ranking from previous months with sales of $2,090. The XTabs - Indica High Dose Tablets 20-Pack (1000mg) and XTabs - Hybrid High Dose Tablets 20-Pack (1000mg) also held steady in second and third positions respectively, showing consistent customer preference for high-dose capsules. Little Helpers - CBN/THC/Melatonin 3:2 Sleep Mints 20-Pack (60mg CBN, 40mg THC, 20mg Melatonin) remained the fourth top-selling product, demonstrating stable demand in the edible category. Little Helpers - CBD/THC 2:1 Calm Mints 20-Pack (100mg CBD, 50mg THC) retained its fifth place, with a slight increase in sales compared to February 2026. Overall, Kikoko's product rankings show a strong consistency, with no changes in order from previous months, indicating a steady consumer base for their top products.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
